AlphaMark Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-40
| Closed | -$23K | – | 619 |
|
2019
Q4 | $23K | Sell |
40
-1
| -2% | -$575 | 0.01% | 260 |
|
2019
Q3 | $27K | Hold |
41
| – | – | 0.01% | 245 |
|
2019
Q2 | $31K | Hold |
41
| – | – | 0.01% | 240 |
|
2019
Q1 | $29K | Hold |
41
| – | – | 0.01% | 231 |
|
2018
Q4 | $19K | Hold |
41
| – | – | 0.01% | 251 |
|
2018
Q3 | $35K | Hold |
41
| – | – | 0.01% | 244 |
|
2018
Q2 | $28K | Buy |
41
+1
| +3% | +$683 | 0.01% | 270 |
|
2018
Q1 | $18K | Hold |
40
| – | – | 0.01% | 299 |
|
2017
Q4 | $18K | Hold |
40
| – | – | 0.01% | 296 |
|
2017
Q3 | $20K | Hold |
40
| – | – | 0.01% | 276 |
|
2017
Q2 | $22K | Hold |
40
| – | – | 0.01% | 263 |
|
2017
Q1 | $26K | Hold |
40
| – | – | 0.01% | 241 |
|
2016
Q4 | $13K | Hold |
40
| – | – | 0.01% | 290 |
|
2016
Q3 | $12K | Buy |
+40
| New | +$12K | 0.01% | 234 |
|